Aloe Vera
Aloe Vera is used in private-label gummy formulations. EU-compliant sourcing and dose ranges available on request.
Why brands use Aloe Vera
Aloe Vera is reviewed by DAT for gummy formulation fit, target-market positioning and documentation requirements before any feasibility commitment.
The above is generic ingredient context. Specific health claims that may appear on consumer-facing pack copy depend on dose and target market — DAT reviews wording per project against EU 1924/2006 and the authorised list under EU 432/2012.
Typical positioning angles
- Reviewed per brief and target market
Claims & compliance
Claim wording for this ingredient depends on the final dose, the full formulation and the target market. DAT reviews wording per project against EU Regulation 1924/2006 and the authorised list under EU 432/2012; UK and non-EU markets are reviewed against the corresponding local framework. No final claim wording is implied by this page.
Documentation by stage
Documentation is supplied as the project progresses. Batch-release documents are issued after production and QC release.
- 01
Early formulation review
- Indicative feasibility for gummy format
- Initial claim wording reviewed against EU 1924/2006 / 432/2012
- High-level dose anchor for the target market
- 02
Specification stage
- Per-SKU specification with quantitative breakdown
- Allergen statement aligned to EU 1169/2011
- Indicative shelf-life and storage conditions
- 03
Production & QC
- In-process control plan
- Stability data underpinning the on-pack BBE
- Pack artwork sign-off record
- 04
Post-production batch documents
- Batch-specific Certificate of Analysis (after QC release)
- Batch traceability record
- Release for shipment notification
Documentation availability depends on product, market and project stage.